Catechol-O-Methyltransferase (COMT) Protein Expression and Activity after Dopaminergic and Noradrenergic Lesions of the Rat Brain-Reference-Cited by-同舟云学术

Catechol-O-Methyltransferase (COMT) Protein Expression and Activity after Dopaminergic and Noradrenergic Lesions of the Rat Brain

Published:2013-04-16 Issue:4 Volume:8 Page:e61392
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Schendzielorz Nadia,Oinas Juha-Pekka,Myöhänen Timo T.,Reenilä Ilkka,Raasmaja Atso,Männistö Pekka T.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors;PT Männistö;Pharmacol Rev,1999

2. Striatal membrane-bound and soluble catechol-O-methyl-transferase after selective neuronal lesions in the rat;S Kaakkola;J Neur Transm,1987

3. Localization of catechol-O-methyltransferase in the leptomeninges, choroid plexus and ciliary epithelium: Implications for the separation of central and peripheral catechols;GP Kaplan;Brain Res,1981

4. Distinct cellular localization of membrane-bound and soluble forms of catechol-O-methyltransferase in brain;AJ Rivett;J Neurochem,1983

5. Catechol-O-methyltransferase (COMT) in rat brain: Immunoelectron microscopic study with an antiserum against rat recombinant COMT protein;T Karhunen;Neurosc Lett,1995

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial Molecular Mechanisms of the Pathogenesis of Parkinson’s Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease;International Journal of Molecular Sciences;2024-01-22

2. Limiting Monoamines Degradation Increases L-DOPA Pro-Locomotor Action in Newborn Rats;International Journal of Molecular Sciences;2023-09-29

3. DESI-MSI-based technique to unravel spatial distribution of COMT inhibitor Tolcapone;International Journal of Pharmaceutics;2023-02

4. Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?;Clinical Parkinsonism & Related Disorders;2022

5. Experimental Dopamine Reuptake Inhibitors in Parkinson’s Disease: A Review of the Evidence;Journal of Experimental Pharmacology;2021-03